Navigating the Nasal–Brain Nexus: Intranasal Delivery of Therapeutics for Brain Tumors – from Direct Nose-to-Brain Transport to Multidimensional Antitumor Mechanisms

鼻腔给药 药物输送 医学 中枢神经系统 神经科学 血脑屏障 三叉神经 药理学 体内 药品 鼻腔 脑瘤 靶向给药 癌症研究 临床试验 粘液 嗅粘膜 神经可塑性 药代动力学 动物模型 表观遗传学 病变 胶质母细胞瘤 胶质瘤
作者
Ruijun Wang,Rile Ge,Zhiqi Li,Yuanming Pan,Zhanbiao He
出处
期刊:International Journal of Nanomedicine [Dove Medical Press]
卷期号:Volume 21: 1-50
标识
DOI:10.2147/ijn.s638425
摘要

Abstract: Intranasal drug delivery represents a non-invasive, brain-targeted therapeutic strategy that bypasses the blood-brain barrier primarily through the olfactory and trigeminal nerve pathways, enabling efficient therapeutic entry into the central nervous system for brain tumor treatment. This review systematically examines the anatomical foundations, pharmacokinetic profiles, and therapeutic applications of this route in glioblastoma (GB), medulloblastoma, and meningioma. Based on nasal mucosal physiology, delivery systems are classified into solutions, gels, particulate carriers, and nanovesicles. Their design must match mucus thickness, mucociliary clearance, and target expression to achieve prolonged retention and precise delivery. Material selection—including natural/synthetic polymers, lipids, and biomimetic membranes—offers distinct advantages; physicochemical parameters such as size, surface charge, and deacetylation degree critically influence mucus penetration, cellular uptake, and biocompatibility. Intranasal delivery significantly increases brain drug concentration and tumor targeting index, prolonging survival in animal models. It exerts multidimensional antitumor effects by modulating neurotransmitters, reshaping neuroinflammation, regulating neuronal plasticity and circuits, influencing the gut–microbiota–brain axis, and intervening in epigenetic mechanisms. Preliminary clinical trials confirm safety and potential efficacy, but challenges remain: dose limitations, inter-individual variability, formulation stability, and unclear regulatory pathways. Future research should focus on smart responsive systems, nasal–brain tumor pharmacokinetic/pharmacodynamic models, and patient-specific 3D-printed nasal models to enhance diagnostic–therapeutic integration. Combining in situ imaging, cross-species physiological databases, and standardized guidelines may accelerate clinical translation, positioning intranasal delivery as a key component of comprehensive brain tumor therapy. A) Strengths quadrant with heading, Strengths and five labeled points with medical icons. S1, BBB bypass. Olfactory and trigeminal routes. Brain concentration: 2.5 to 5 times IV. S2, Rapid absorption. T max: 15 to 30 min asterisk. S3, Brain-directed exposure. Brain AUC: 10.5 times IV asterisk. Plasma AUC: 10 to 33 percent of IV. S4, Noninvasive administration. Potential for trained self-administration. S5, Avoidance of hepatic first pass. For directly absorbed fractions. Icons show a nasal cavity and brain, a nasal tissue cross section, a blood vessel cross section, a clock, a person using a nasal spray and a liver with gastrointestinal tract. B) Weaknesses quadrant with heading, Weaknesses and five labeled points with nasal and formulation icons. W1, Limited dose volume. Human volume: 100 to 200 micro liter per nostril asterisk. W2, Anatomical variability. Interindividual AUC CV: 30 to 50 percent. W3, Mucociliary clearance. Clearance half-time: 15 to 20 min asterisk. W4, Enzymatic degradation. Peptides and proteins are vulnerable. W5, Formulation instability. Aggregation, leakage and activity loss. Icons include a nasal spray directed into a nasal cavity, multiple nasal cavity cross sections indicating variability, a mucosal surface with particles above it and molecular and particle clusters. C) Opportunities quadrant with heading, Opportunities and five labeled points with therapy, imaging, modeling and device icons. O1, Combination therapy. Radiotherapy plus immunotherapy. Example MST: 28 to 70 days asterisk. O2, Theranostic platforms. MRI slash fluorescence plus drug delivery. O3, Personalized 3D nasal models. Deposition prediction accuracy greater than 85 percent asterisk. O4, Smart-responsive carriers. pH slash ROS slash enzyme-triggered release. O5, CFD-optimized devices. Spray size, angle and airflow. Icons include a brain with symbols around it, medical scan style images, a nasal model in a rectangular frame, a circular particle with surrounding dots and a nasal spray with airflow paths. D) Threats quadrant with heading, Threats and five labeled points with regulatory, manufacturing, safety, cost and device icons. T1, Regulatory complexity. Product-specific drug-device pathway. T2, GMP scale-up. Batch consistency and sterile production. T3, Long-term safety gaps. Nasal, olfactory and CNS monitoring. T4, Development cost. Manufacturing and trial investment. T5, Device standardization. Performance comparability across devices. Icons include a government building, manufacturing vessels and containers, a nasal tissue strip with a brain and a clock, documents with a chart and coin stacks and multiple nasal spray device shapes.A SWOT infographic on intranasal drug delivery listing strengths, weaknesses, opportunities and threats. Keywords: transnasal administration, brain tumors, brain-targeted delivery, neurotransmitter regulation, epigenetic regulation
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
rosy完成签到,获得积分10
刚刚
科目三的应助被天道酬勤采纳,获得10
1秒前
hxxcyb完成签到,获得积分10
1秒前
2秒前
3秒前
3秒前
小二郎的应助被高梓轩采纳,获得10
4秒前
kwokai发布了新的文献求助10
4秒前
ori12138完成签到,获得积分10
5秒前
尺八发布了新的文献求助10
7秒前
酷酷天蓝完成签到 ,获得积分10
7秒前
7秒前
cui完成签到,获得积分20
7秒前
8秒前
李静静发布了新的文献求助10
8秒前
冷静冷雪完成签到,获得积分20
9秒前
zw完成签到 ,获得积分20
9秒前
10秒前
HHH完成签到,获得积分10
10秒前
11秒前
11秒前
做梦发布了新的文献求助10
11秒前
13秒前
罗斯味SF发布了新的文献求助10
14秒前
sh完成签到 ,获得积分10
14秒前
MeiyanZou完成签到,获得积分10
15秒前
llll发布了新的文献求助10
15秒前
情怀的应助被王贺采纳,获得10
15秒前
15秒前
Duomo发布了新的文献求助10
15秒前
15秒前
miyana发布了新的文献求助10
16秒前
陈静风发布了新的文献求助10
16秒前
17秒前
17秒前
17秒前
HPHT完成签到,获得积分10
17秒前
19秒前
molihuakai的应助被jimiha采纳,获得10
19秒前
汤一德发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192078
求助须知:如何正确求助?哪些是违规求助? 9578670
关于积分的说明 21861341
捐赠科研通 7791469
什么是DOI,文献DOI怎么找? 3436771
关于科研通互助平台的介绍 2560538
邀请新用户注册赠送积分活动 2483557